Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65.9M
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
17.5M
-
Shares change
-
-243K
-
Total reported value, excl. options
-
$152M
-
Value change
-
-$2M
-
Put/Call ratio
-
2.29
-
Number of buys
-
41
-
Number of sells
-
-39
-
Price
-
$8.68
Significant Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q1 2021
108 filings reported holding CTSO - Cytosorbents Corp - Common Stock, par value $0.001 per share as of Q1 2021.
Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.5M shares
of 65.9M outstanding shares and own 26.52% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.83M shares), Redmile Group, LLC (2.13M shares), VANGUARD GROUP INC (2.1M shares), Skylands Capital, LLC (1.58M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (912K shares), Neuberger Berman Group LLC (864K shares), Sargent Investment Group, LLC (784K shares), STATE STREET CORP (658K shares), GEODE CAPITAL MANAGEMENT, LLC (657K shares), and NORTHERN TRUST CORP (427K shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.